PITTSBURGH, 29. Januar 2026 /PRNewswire/ — MolecuLight gab heute bekannt, dass sein MolecuLightDX® Wundmessgerät von der US-amerikanischen Food and Drug Administration (FDA) als Medical Device Development Tool (MDDT) qualifiziert wurde. Das MDDT-Programm der FDA qualifiziert ausgewählte, wissenschaftlich validierte Instrumente für den Einsatz in der Entwicklung und Bewertung von Medizinprodukten und ermöglicht es Sponsoren, in klinischen Untersuchungen… Continue reading FDA qualifiziert MolecuLightDX Wundmessung als Medical Device Development Tool (MDDT) zur Evaluierung neuer Produkte in der Wundversorgung
Author: PR Newswire Online News
La FDA qualifie MolecuLightDX Wound Measurement comme outil de développement de dispositifs médicaux (MDDT) pour l’évaluation de nouveaux produits dans le domaine du traitement des plaies.
PITTSBURGH, 29 janvier 2026 /PRNewswire/ — MolecuLight a annoncé aujourd’hui que son appareil de mesure des plaies MolecuLightDX® a été qualifié par la Food and Drug Administration (FDA) des États-Unis en tant qu’outil de développement de dispositifs médicaux (MDDT). Le programme MDDT de la FDA qualifie des outils sélectionnés et scientifiquement validés pour une utilisation dans… Continue reading La FDA qualifie MolecuLightDX Wound Measurement comme outil de développement de dispositifs médicaux (MDDT) pour l’évaluation de nouveaux produits dans le domaine du traitement des plaies.
FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
PITTSBURGH, Jan. 29, 2026 /PRNewswire/ — MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The FDA’s MDDT program qualifies select, scientifically validated tools for use in medical device development and evaluation, enabling sponsors to generate reliable, FDA accepted… Continue reading FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
PITTSBURGH, Jan. 29, 2026 /PRNewswire/ – MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The FDA’s MDDT program qualifies select, scientifically validated tools for use in medical device development and evaluation, enabling sponsors to generate reliable, FDA… Continue reading FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
Sports Nutrition Market Size Expected to Reach USD 108.1 Billion by 2035, Growing at a CAGR of 7.55% | Research by Vantage Market Research
NEW YORK, Jan. 29, 2026 /PRNewswire/ — The Global Sports Nutrition Market is experiencing a strong transformation as consumers worldwide increasingly prioritize physical fitness, active lifestyles, and performance-oriented nutrition. Rising participation in sports and fitness activities, growing awareness of preventive health, and increasing demand for functional and clean-label nutritional products are accelerating the adoption of sports… Continue reading Sports Nutrition Market Size Expected to Reach USD 108.1 Billion by 2035, Growing at a CAGR of 7.55% | Research by Vantage Market Research
Enfinity Global pone en marcha el primer proyecto de su portafolio de 366 MW en PPAs con Microsoft en Italia
MILÁN, 29 de enero de 2026 /PRNewswire/ — Enfinity Global ha anunciado hoy la entrada en operación comercial del primer proyecto de su cartera de PPAs (Power Purchase Agreements) con Microsoft en Italia. La puesta en marcha de esta planta solar fotovoltaica, con una capacidad de 33,8 MW AC, marca el inicio de una relación… Continue reading Enfinity Global pone en marcha el primer proyecto de su portafolio de 366 MW en PPAs con Microsoft en Italia
H.I.G. WhiteHorse Provides Financing to Büter Group
LONDON, Jan. 29, 2026 /PRNewswire/ — H.I.G. WhiteHorse, the credit affiliate of H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that it has provided a new first lien, senior-secured credit facility to Büter Group (“Büter”, or “the Company”), a portfolio company of NPM… Continue reading H.I.G. WhiteHorse Provides Financing to Büter Group
National Council on Problem Gambling Adopts 1-800-MY-RESET as New National Problem Gambling Helpline™ Number
WASHINGTON, Jan. 29, 2026 /PRNewswire/ — The National Council on Problem Gambling (NCPG) today announced it has adopted 1-800-MY-RESET as the new National Problem Gambling Helpline™ number, designed to be memorable and easily accessible for the public. 1-800-MY-RESET is now live and operational to receive calls. The adoption of the new number strengthens national visibility… Continue reading National Council on Problem Gambling Adopts 1-800-MY-RESET as New National Problem Gambling Helpline™ Number
Kroll Launches New Practices Leveraging Technology and AI to Accelerate Decision-Making and Achieve Competitive Advantage
Kroll Economics and Decision Intelligence Extend Solutions in Growth Markets NEW YORK, Jan. 29, 2026 /PRNewswire/ — Kroll, the leading independent provider of global financial and risk advisory solutions, today announced the launch of new practices – Kroll Economics and Decision Intelligence. This strategic move is in direct response to market demand for access to clear,… Continue reading Kroll Launches New Practices Leveraging Technology and AI to Accelerate Decision-Making and Achieve Competitive Advantage
CLEAR CEO CARYN SEIDMAN BECKER ELECTED AS A CLASS B DIRECTOR TO NEW YORK FED BOARD OF DIRECTORS
The directors of the Reserve Banks act as an important link between the Federal Reserve and the private sector, ensuring that the Fed’s decisions on monetary policy are informed by actual economic conditions NEW YORK, Jan. 29, 2026 /PRNewswire/ — CLEAR (NYSE: YOU), the secure identity company, is pleased to announce that Caryn Seidman Becker, chairman… Continue reading CLEAR CEO CARYN SEIDMAN BECKER ELECTED AS A CLASS B DIRECTOR TO NEW YORK FED BOARD OF DIRECTORS